Exciting times in the world of AI! The FDA recently launched its agency-wide language model, Elsa, a bit ahead of schedule. While innovation is crucial, rushing out such powerful tools can lead to unintended challenges. From my perspective, it’s essential to strike a balance between speed and thorough testing, especially in fields that impact public health. The implications of AI in regulatory processes are vast, and we need to ensure that we’re not compromising quality for haste. Have you encountered any AI tools in your industry that felt rushed or underprepared? I’d love to hear your experiences and thoughts on this!